Capital Asset Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Buy
1,182
+384
+48% +$142K 0.02% 218
2026
Q1
$255K Sell
798
-111
-12% -$36.5K 0.01% 258
2025
Q4
$337K Buy
+909
New +$307K 0.01% 220
2024
Q4
– Sell
-459
Closed -$225K – 316
2024
Q3
$225K Sell
459
-5
-1% -$2.67K 0.01% 299
2024
Q2
$246K Buy
+464
New +$245K 0.01% 273

Other funds holding ELV

Capital Asset Advisory Services's ELV Position: Q2 2026 in Review

Capital Asset Advisory Services increased its Elevance Health (ELV) stake by 48% in Q2 2026, buying an estimated $142K and bringing the position to 1,182 shares worth $457K. The position accounts for 0.02% of the portfolio, ranked #218.

Capital Asset Advisory Services first reported a position in ELV in Q2 2024 and has held it in 5 quarters since. 1,612 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Capital Asset Advisory Services held 1,182 shares of Elevance Health worth $457K as of Q2 2026.
  • Capital Asset Advisory Services bought 384 Elevance Health shares in Q2 2026, an estimated $142K.
  • Elevance Health made up 0.02% of Capital Asset Advisory Services's portfolio in Q2 2026, its #218 holding.
  • Capital Asset Advisory Services first reported a position in Elevance Health in Q2 2024 and has held it in 5 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Capital Asset Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.